Molecular cloning and characterisation of a novel type of human papillomavirus 160 isolated from a flat wart of an immunocompetent patient

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Mitsuishi, Tsuyoshi ^a   Ohsawa, Ikuroh ^b   Kato, Toshihiko ^c   Egawa, Nagayasu ^d   Kiyono, Tohru ^d  

^a Tokyo Women s Medical University   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E1; GLYCOPROTEIN E2; L1 PROTEIN; L2 PROTEIN; PROTEIN E4; PROTEIN E6; PROTEIN E7; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; DNA BASE COMPOSITION; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS 160; HUMAN TISSUE; MOLECULAR CLONING; MOLECULAR PHYLOGENY; NONHUMAN; OPEN READING FRAME; VERRUCA VULGARIS; VIRUS IDENTIFICATION; VIRUS ISOLATION; WART VIRUS; ALPHAPAPILLOMAVIRUS; AMINO ACID SEQUENCE; BINDING SITE; CHEMISTRY; CLASSIFICATION; GENETICS; IMMUNOCOMPETENCE; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PHYLOGENY; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; VIROLOGY; VIRUS GENOME;

ADOLESCENT; ADULT; AGED; ALPHAPAPILLOMAVIRUS; AMINO ACID SEQUENCE; BINDING SITES; CHILD; CLONING, MOLECULAR; DNA, VIRAL; GENOME, VIRAL; GENOTYPE; HUMANS; IMMUNOCOMPETENCE; MIDDLE AGED; OPEN READING FRAMES; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, PROTEIN; VIRAL PROTEINS; WARTS;

EID: 84892527588     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079592     Document Type: Article

References (23)

1. Kovanda A, Kocjan BJ, Luzar B, Bravo IG, Poljak M (2011) Characterization of novel cutaneous human papillomavirus genotypes HPV-150 and HPV-151. PLOS ONE 6: e22529. doi:10.1371/journal.pone.0022529. PubMed: 21799888.
2. de Villiers EM; (2013) Cross-roads in the classification of papillomaviruses. Virology Volumes 13: 00245-6 doi:10.1016/j.virol.2013.04.023. [Epub ahead of print]
3. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of papillomaviruses. Virology 324: 17-27. doi: 10.1016/j.virol.2004.03.033. PubMed: 15183049.
4. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen Hz et al. (2010) Classification of papillomaviruses. PVs based on 189 PV types and proposal of taxonomic amendments. Virology 401(1):70-9.
5. Schulz E, Gottschling M, Wibbelt G, Stockfleth E, Nindl I (2009) Isolation and genomic characterization of the first Norway rat (Rattus norvegicus) papillomavirus and its phylogenetic position within Pipapillomavirus, primarily infecting rodents. J Gen Virol 9: 0(Pt 11): 2609-14 PubMed: 19605590.
6. Sasagawa T, Mitsuishi T (2012) Novel polymerase chain reaction method for detecting cutaneous human papillomavirus DNA. J Med Virol 84: 138-144. doi:10.1002/jmv.22195. PubMed: 22052582.
7. Tamura K, Peterson D, Peterson N, Stecher G, Nei M et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731-2739. doi:10.1093/molbev/msr121. PubMed: 21546353.
8. Dyson N, Howley PM, Münger K, Harlow E (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934-937. doi:10.1126/science.2537532. PubMed: 2537532.
9. Werness BA, Levine AJ, Howley PM (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248(4951): 76-79. doi:10.1126/science.2157286. PubMed: 2157286.
10. Kiyono T, Hiraiwa A, Fujita M, Hayashi Y, Akiyama T et al. (1997) Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci USA 94:11612-6.
11. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA et al. (1998) Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396(6706):84-8
12. Gammoh N, Grm HS, Massimi P, Banks L (2006) Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator. J Virol 80:1787-97.
13. Nominé Y, Masson M, Charbonnier S, Zanier K, Ristriani T et al. (2006) Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis. Mol Cell 21: 665-678. doi:10.1016/j.molcel.2006.01.024. PubMed: 16507364.
14. Liu X, Clements A, Zhao K, Marmorstein R (2006) Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor. J Biol Chem 281: 578-586. doi:10.1074/jbc. M508455200. PubMed: 16249186.
15. Mantovani F, Banks L (2001) The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20: 7874-7887. doi:10.1038/sj.onc.1204869. PubMed: 11753670.
16. Moran E (1993) DNA tumor virus transforming proteins and the cell cycle. Curr Opin Genet Dev 3: 63-70. doi:10.1016/S0959-437X(05)80342-9. PubMed: 8453277.
17. Lee JO, Russo AA, Pavletich NP (1998) Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature 391(6670): 859-865. doi:10.1038/36038. PubMed: 9495340.
18. Chan HM, Smith L, La Thangue NB (2001) Role of LXCXE motif-dependent interactions in the activity of the retinoblastoma protein. Oncogene 20: 6152-6163. doi:10.1038/sj.onc.1204793. PubMed: 11593423.
19. Singh M, Krajewski M, Mikolajka A, Holak TA (2005) Molecular determinants for the complex formation between the retinoblastoma protein and LXCXE sequences. J Biol Chem 280: 37868-37876. doi: 10.1074/jbc.M504877200. PubMed: 16118215.
20. Boulet G, Horvath C, Vanden Broeck D, Sahebali S, Bogers J (2007) Human papillomavirus: E6 and E7 oncogenes. Int J Biochem Cell Biol 39: 2006-2011. doi:10.1016/j.biocel.2007.07.004. PubMed: 17768080.
21. Narechania A, Terai M, Chen Z, DeSalle R, Burk RD (2004) Lack of the canonical pRB-binding domain in the E7 ORF of artiodactyl papillomaviruses is associated with the development of fibropapillomas. J Gen Virol 85(5): 1243-1250. doi:10.1099/vir.0.19765-0.
22. Ueno T, Sasaki K, Yoshida S, Kajitani N, Satsuka A, Nakamura H et al. (2006) Molecular mechanisms of hyperplasia induction by human papillomavirus E7. Oncogene 25: 4155-4164. doi:10.1038/sj.onc.1209445. PubMed: 16501608.
23. Cardoso JC, Calonje E (2011) Cutaneous manifestations of human papillomaviruses: a review.Acta Dermatovenerol Alp Panonica Adriat 20: 145-154. PubMed: 22131115.